Testing effectiveness (Phase 2)Study completedNCT01152710
What this trial is testing
Capecitabine as Radiosensitising Agent in Neoadjuvant Treatment of Locally Advanced Resectable Rectal Cancer
Who this might be right for
Resectable Rectal Cancer Clinical Stage II and III
Institute of Oncology Ljubljana 57